237 related articles for article (PubMed ID: 6427336)
21. Constitutive production of a factor supporting B lymphocyte differentiation by a T cell hybridoma.
Elkins K; Cambier JC
J Immunol; 1983 Mar; 130(3):1247-51. PubMed ID: 6337214
[TBL] [Abstract][Full Text] [Related]
22. T cell-derived B cell growth factor(s) can induce stimulation of both resting and activated B cells.
Thompson CB; Schaefer ME; Finkelman FD; Scher I; Farrar J; Mond JJ
J Immunol; 1985 Jan; 134(1):369-74. PubMed ID: 3917279
[TBL] [Abstract][Full Text] [Related]
23. B cell-derived BCGF functions as autocrine growth factor(s) in normal and transformed B lymphocytes.
Muraguchi A; Nishimoto H; Kawamura N; Hori A; Kishimoto T
J Immunol; 1986 Jul; 137(1):179-86. PubMed ID: 3486912
[TBL] [Abstract][Full Text] [Related]
24. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
Procopio AD; Allavena P; Ortaldo JR
J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
[TBL] [Abstract][Full Text] [Related]
25. Distinction of B cell maturation factors from lymphokines affecting B cell growth and viability.
Sherris DI; Sidman CL
J Immunol; 1986 Feb; 136(3):994-8. PubMed ID: 3079808
[TBL] [Abstract][Full Text] [Related]
26. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line.
Yoshizaki K; Nakagawa T; Fukunaga K; Tseng LT; Yamamura Y; Kishimoto T
J Immunol; 1984 Jun; 132(6):2948-54. PubMed ID: 6202767
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight.
Mehta SR; Grant SR; Maizel AL
J Immunol; 1986 Oct; 137(7):2210-4. PubMed ID: 3093567
[TBL] [Abstract][Full Text] [Related]
28. Partial purification and characterization of B cell growth factor constitutively secreted by human T-cell hybridoma.
Pathak SK; Tsang KY; Cathcart MK; Arnaud P; Boutin B; Fudenberg HH
Immunol Lett; 1985; 10(6):339-46. PubMed ID: 3930398
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
[TBL] [Abstract][Full Text] [Related]
30. Purification and partial characterization of human intracellular B cell growth factor.
Sahasrabuddhe CG; Martin B; Maizel AL
Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330
[TBL] [Abstract][Full Text] [Related]
31. Functional properties of two human B cell growth factor species separated by lectin affinity column.
Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P
J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105
[TBL] [Abstract][Full Text] [Related]
32. Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.
Muraguchi A; Kehrl JH; Butler JL; Fauci AS
J Immunol; 1984 Jan; 132(1):176-80. PubMed ID: 6197443
[TBL] [Abstract][Full Text] [Related]
33. A B cell growth factor-like activity is secreted by cloned, neoplastic B cells.
Brooks KH; Uhr JW; Vitetta ES
J Immunol; 1984 Dec; 133(6):3133-7. PubMed ID: 6333454
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human B cell proliferation by prostaglandin E2.
Thompson PA; Jelinek DF; Lipsky PE
J Immunol; 1984 Nov; 133(5):2446-53. PubMed ID: 6332851
[TBL] [Abstract][Full Text] [Related]
35. Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and -stimulating activity.
Takahama Y; Ono S; Hara Y; Hayashi S; Dobashi K; Hamaoka T
J Immunol; 1985 Oct; 135(4):2534-40. PubMed ID: 3897376
[TBL] [Abstract][Full Text] [Related]
36. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
Gordon J; Webb AJ; Walker L; Guy GR; Rowe M
Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody NIM-R3 substitutes for B-cell growth factor.
Greenwood MR; Parkhouse RM
Immunology; 1986 Sep; 59(1):7-13. PubMed ID: 3489671
[TBL] [Abstract][Full Text] [Related]
39. B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2.
Mingari MC; Gerosa F; Moretta A; Zubler RH; Moretta L
Eur J Immunol; 1985 Feb; 15(2):193-6. PubMed ID: 3871701
[TBL] [Abstract][Full Text] [Related]
40. Frequent coexpression of cytolytic activity and lymphokine production among human T lymphocytes. Production of B cell growth factor and interleukin 2 by T8+ and T4+ cytolytic clones.
Mingari MC; Moretta A; Maggi E; Pantaleo G; Gerosa F; Romagnani S; Moretta L
Eur J Immunol; 1984 Nov; 14(11):1066-9. PubMed ID: 6333987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
